GEXVAL

gexval-logo

GEXVal is to help patients and families fighting against orphan and intractable diseases

#People #Financial #Website #More

GEXVAL

Industry:
Emergency Medicine Health Care

Founded:
2018-02-01

Address:
Fujisawa, Kanagawa, Japan

Country:
Japan

Website Url:
http://www.gexval.com

Total Employee:
1+

Status:
Active

Total Funding:
1.11 B JPY



Current Advisors List

not_available_image

Ojima Mami Director Chief Knowledge Officer @ GEXVal
Board_member

Current Employees Featured

not_available_image

Takako Naito
Takako Naito Research Alliance, Chief, Co-Founder @ GEXVal
Research Alliance, Chief, Co-Founder

juran-kato_image

Juran Kato
Juran Kato President and CEO @ GEXVal
President and CEO

not_available_image

Makoto Shimazaki
Makoto Shimazaki Director @ GEXVal
Director

not_available_image

Lili Mao
Lili Mao Chief Science Officer and Co-Founder @ GEXVal
Chief Science Officer and Co-Founder

Founder


not_available_image

Lili Mao

not_available_image

Takako Naito

Investors List

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Series B - GEXVal

ebest-33b0_image

eBEST

eBEST investment in Series B - GEXVal

yokohama-capital_image

Yokohama Capital

Yokohama Capital investment in Series B - GEXVal

tnp-threads-of-light_image

TNP Threads Of Light

TNP Threads Of Light investment in Series B - GEXVal

shiratori-pharmaceuticals_image

Shiratori Pharmaceuticals

Shiratori Pharmaceuticals investment in Series B - GEXVal

healthcare-innovation_image

Healthcare Innovation

Healthcare Innovation investment in Series B - GEXVal

tnp-threads-of-light_image

TNP Threads Of Light

TNP Threads Of Light investment in Series A - GEXVal

takeda-pharmaceutical_image

Takeda

Takeda investment in Series A - GEXVal

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Series A - GEXVal

smbc-venture-capital_image

SMBC Venture Capital

SMBC Venture Capital investment in Series A - GEXVal

Official Site Inspections

http://www.gexval.com

  • Host name: www19.gmoserver.jp
  • IP address: 133.130.64.128
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "GEXVal"

GEXVal

Oct 3, 2024 Our goal is to help patients and families fighting against orphan and intractable diseasesSee details»

GEXVal

Oct 3, 2024 GEXVal Participates in BIO-EUROPE ® 2024 2024/10/29 GEXVal Selected as Finalist for CITELINE JAPAN AWARDS 2024 in Categories: EXECUTIVE OF THE YEAR & FINANCING DEAL OF THE YEAR 2024/10/8 โ€ฆSee details»

Our company - GEXVal

The acronym GEXVal was devised as a shortened form of Generate Extra Value, which refers to the process of identifying such promising compounds and nurturing new value through โ€ฆSee details»

Gexval - Crunchbase Company Profile & Funding

GEXVal is a research and development-oriented drug discovery company. The company specializes in the creation of treatments for rare and incurable diseases. The mission of GEXVal is to provide patients and families with the rare and โ€ฆSee details»

GexVal Company Profile 2024: Valuation, Funding & Investors

GexVal General Information Description. Developer of a drug designed to focus on orphan and intractable diseases. The company develops compounds for the treatment of rare diseases in โ€ฆSee details»

GEXVal Inc. - AEA

Nov 7, 2023 GEXVal, a Japan-based clinical-stage biopharma founded as a Takeda Pharmaceutical spin-off, tackles โ€œAccess to Medicineโ€ issues in rare diseases and โ€ฆSee details»

GEXVAL INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for GEXVAL INC. of FUJISAWA, KANAGAWA. Get the latest business insights from Dun & Bradstreet.See details»

GEXVal Inc. - AEA

GEXVal, a Japan-based clinical-stage biopharma founded as a Takeda Pharmaceutical spin-off, tackles โ€œAccess to Medicineโ€ issues in rare diseases and underserved medical conditions. As โ€ฆSee details»

GEXVal - Company Profile - Tracxn

Oct 11, 2024 GEXVal - Developer of small molecule based therapeutics for the treatment of orphan and intractable diseases. Raised a total funding of $3.06M over 2 rounds from 6 โ€ฆSee details»

GEXVal - Products, Competitors, Financials, Employees, โ€ฆ

GEXVal. Frequently Asked Questions (FAQ) When was GEXVal founded? GEXVal was founded in 2018. Where is GEXVal's headquarters? GEXVal's headquarters is located at 2-26-1 โ€ฆSee details»

Gexval - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Dec 4, 2023: Series C - Gexval . 5: ¥450M โ€” Sep โ€ฆSee details»

GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets

Emerging Company Profile: Japanese company GEXVal is one of several bioventures formed from the spin-out of researchers and assets from Takeda, and is focused on bringing therapies โ€ฆSee details»

Gexval - Contacts, Employees, Board Members, Advisors & Alumni โ€ฆ

Organization. Gexval . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board โ€ฆSee details»

To investors - GEXVal

To Investors, GEXVal is a pharma spin-out drug discovery startup based in Japan.. Our mission is to G enerate Ex tra Val ue to deliver cost-effective treatment to improve health and QoL of โ€ฆSee details»

Gexval, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Gexval, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, Unknown, โ€ฆSee details»

GEXVal Inc - VentureRadar

" GEXVal is a pharma spin-out drug discovery startup based in Japan. Our mission is to Generate Extra Value to deliver cost-effective treatment to improve health and QoL of patients and โ€ฆSee details»

GEXVal Completed the Close of New Funding Round with JPY 450 โ€ฆ

GEXVal Inc. 4 December 2023. GEXVal Completed the Close of New Funding Round with JPY 450 Million (USD 3 Million) GEXVal Inc. (President & CEO: Juran Kato, Kanagawa, Japan), a โ€ฆSee details»

GEXVal is Listed in JETRO Japan Startup Market Map

Apr 21, 2023 We are pleased to announce that GEXVal Inc. is listed in the Japan startup market map launched by JETRO (Japan External Trade Organization). This is a map collection that โ€ฆSee details»

Gexval - Tech Stack, Apps, Patents & Trademarks - Crunchbase

The intellectual property of Gexval includes 2 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Gexval has โ€ฆSee details»

GEXVal Inc. Announces Collaboration with FRAXA-DVI

GEXVal Inc. February 28, 2023. GEXVal Inc. is pleased to announce that we have initiated a collaboration project with FRAXA *-DVI ** (FRAXA-Drug Validation Initiative) ... FRAXA โ€ฆSee details»

linkstock.net © 2022. All rights reserved